S 67 would increase Vermont's minimum wage to $18.60 per hour starting January 1, 2026, and adjust it annually based on the lower of a 5% increase or the previous year's consumer price index (CPI). It defines "livable wage" as the hourly rate needed for a full-time worker in shared housing with employer health insurance to cover basic needs, as calculated by Vermont's Joint Fiscal Office. This bill directly affects all Vermont employers who currently pay the state's minimum wage, requiring them to raise wages to meet this new standard. The change takes effect on July 1, 2025, with the first adjusted rate applying in 2026.
H 46 establishes the Rare Disease Advisory Council within the Department of Health to address the needs of individuals living with rare diseases in Vermont. This council will conduct needs assessments to identify service gaps for patients and caregivers, and develop policy recommendations to improve diagnosis, treatment access, and care quality. It will also provide testimony on legislation impacting the rare disease community and maintain a public resource webpage. Comprised of patients, caregivers, medical professionals, and state officials, the Council aims to offer guidance to the public, the General Assembly, and other government agencies.
This bill changes Vermont's health equity reporting requirements by reducing the frequency of formal reports from annually to every three years, starting in 2028. The Department of Health must still analyze and publish data on racial/ethnic disparities, language, disability, and other equity factors biannually on its website, but will submit a consolidated report to legislative committees only every three years. It also updates confidentiality rules for cancer and ALS registries, requiring written data-sharing agreements with researchers or other states and mandating institutional review board approvals before sharing identifiable information. These changes directly affect the Department of Health, cancer/ALS registries, and researchers seeking access to health data.
H 327 requires corporations building new energy facilities (costing over $100,000) after January 1, 2025, to submit two items to Vermont's Public Utility Commission: a line-item budget from the contractor and an attestation confirming either union labor was used at prevailing wage plus 42.5% fringe benefits, or non-union labor paid the mean prevailing wage plus the same fringe benefits. Fringe benefits include health insurance, retirement contributions, and paid leave. The Commission must make these documents publicly available (with personal details removed) and the law takes effect July 1, 2025. This directly affects energy project contractors and developers regulated by the Public Utility Commission.
This bill expands eligibility for Vermont's Dr. Dynasaur program to cover pregnant individuals with incomes up to 312% of the federal poverty level (FPL), effective January 2026. It also requires the Agency of Human Services to study and report by January 2026 on the feasibility and costs of expanding Dr. Dynasaur to all Vermont residents under 26 with incomes at or below 312% FPL, and Medicaid to adults aged 26-64 with incomes at or below 312% FPL. The bill appropriates $600,000 for implementing the pregnant individual eligibility change, with $180,000 from the General Fund and $420,000 in federal funds. The report must address federal waiver needs, cost estimates, and implementation timelines for potential broader expansions. This is a policy change focused on expanding healthcare access for specific income groups, not a procedural measure.
H 305 requires enhanced oversight and informed consent procedures for prescriptions of psychotropic medications (medications for mental health conditions) given to children and youth enrolled in Vermont's Dr. Dynasaur program. The bill mandates that healthcare providers obtain specific, documented consent from parents or guardians before prescribing these medications and establishes clearer accountability measures for monitoring their use. This directly affects children in the Dr. Dynasaur program, their families, and the healthcare providers prescribing these medications. The bill aims to strengthen safeguards around medication management for vulnerable youth without specifying new treatment protocols. (Introduced February 2025, currently before the Health Care Committee.)
H.189 eliminates criminal penalties for possessing or dispensing small personal amounts of drugs in Vermont, directly affecting individuals currently facing misdemeanor charges for such activities. It creates the Community Care, Health, and Safety Special Fund, using 40% of cannabis tax revenue and opioid settlement funds to support community-based harm reduction services, overdose prevention, and substance use treatment. The bill requires law enforcement to provide service referrals (like treatment or harm reduction resources) instead of arresting people for small drug amounts, and establishes a new advisory board to define "personal use" quantities. This shift aims to reduce overdose deaths and racial disparities in drug enforcement while redirecting resources from prosecution toward public health services.
H.292 bans the land application and sale of biosolids, sewage sludge, or similar liquid wastes containing PFAS (perfluoroalkyl substances) after testing confirms their presence. It requires mandatory PFAS testing before any land use or sale and prohibits landfill disposal of such materials if PFAS levels exceed Vermont’s hazardous waste standards. The bill directly affects wastewater treatment facilities, agricultural landowners using sludge as fertilizer, and waste management companies handling these materials. Key provisions include establishing testing protocols, public disclosure of results, and enforcing the bans for both land application and disposal. These changes aim to prevent PFAS contamination in soil and water from waste products.
This bill establishes the Office of Health Equity within Vermont's Department of Health to eliminate health disparities affecting specific populations. It directly affects state agencies, the Department of Health, and Vermont residents who experience health inequities, including Black, Indigenous, and People of Color; LGBTQ+ individuals; and people with disabilities. The office will coordinate efforts to address social, economic, and environmental factors influencing health outcomes, manage data collection on health disparities, and advise on policies and grant distribution. The office becomes effective July 1, 2025, after the Health Equity Advisory Commission develops its structure and recommendations.
This joint resolution (JRS 15) is a symbolic statement of support for Vermont's transgender and non-binary community, not a new law. It reaffirms Vermont's existing commitments to anti-discrimination protections in areas like employment, housing, and healthcare, as well as its policies allowing gender marker changes on vital records and protecting gender-affirming care. The resolution directs the Secretary of State to send a copy to the Pride Center of Vermont and Outright Vermont. It does not create new legal obligations or alter current policies.
